|
|
Symposium 40 - Hematopathology: New Technologies
Tuesday, September 19, 2006 08:00 - 12:00
|
|
Moderators:
|
Dr. John Wing Chan and Dr. Thomas Grogan
|
|
|
Disclosure:
|
In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. Thomas Grogan indicated he is an employee and major share holder for Ventana Medical Systems, Inc. Dr. Reiner Siebert indicated he is a consultant for Abbott/Vysis. All other faculty members for this Symposium have indicated they have no disclosures to make.
|
Click any blue section number below to display text and references for individual lectures:
| New Techniques of Immunohistochemistry (IHC) and in situ Hybridization (ISH) for Lymphoma Diagnosis
Thomas M. Grogan |
| Molecular Profiling Studies of Lymphoma
Wing C. Chan |
| Standardization of PCR Techniques for Assessing Lymphoid Clonality; the Biomed-2 Experience
Thierry Jo Molina |
| New Advances in Cytogenetics - FISH, CGH, and Array-CGH
Reiner Siebert |
| Proteomics and Lymphoid Malignancies
Andrew L. Feldman |
| Introduction to Mass Spectrometry-Based Proteomics
Kojo S. J. Elenitoba-Johnson |
|
|
|
|
